Apollo Endosurgery Taps Michael Doty for CFO
AUSTIN, TX – June 7, 2011 – Apollo Endosurgery, Inc., a leading company in the emerging field of flexible surgery, announced today the appointment of Michael J. Doty as Chief Financial Officer (CFO). Doty most recently served as CFO for Tornier BV, and prepared the company for one of the most successful medical device IPOs in the past few years. Doty formerly served as CFO of Inamed Corporation, a leading provider of devices for bariatric surgery and aesthetic medicine.
“I am enthusiastic about the opportunity at Apollo Endosurgery. Their flexible surgical products are well‐positioned to address a number of important clinical conditions, and they are poised for significant revenue growth,” said Doty. “The flexible suturing platform, OverStitch™, has the potential to fundamentally change patient care in general surgery, bariatric procedures and GI cancers.”
Dennis McWilliams, President and CEO of Apollo Endosurgery, adds “Mike’s breadth of experience – from strategic planning to hands-on value-building – emanates from more than two decades of financial management in technology and health care sectors. We are pleased to leverage this experience as we commercialize our products on a larger scale.”
Doty holds a Masters in Business Administration from the University of St. Thomas and a Bachelor of Chemistry and a Bachelor of Science in Business Administration from the University of Minnesota. He is also a certified public accountant (CPA).
To learn more about flexible surgery instruments, including the OverStitch® Endoscopic Suturing System and the SuMO™ Tissue Access and Resection System develop by Apollo Endosurgery®, visit www.apolloendo.com.
About Apollo Endosurgery®, Inc.
Apollo Endosurgery®, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology. Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas. All of Apollo’s products are compatible with existing flexible endoscope platforms. Apollo Endosurgery® was cofounded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong. The company is funded by PTV Sciences, H.I.G. Ventures and has received a grant from the Cancer Prevention Research Institute of Texas.